Quick Answer
Surgery Partners, Inc. reported Diluted EPS of $0.61 per share (loss) for fiscal year 2025.
Surgery Partners, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$0.61 | +54.1% |
| 2024 | -$1.33 | -1377.8% |
| 2023 | -$0.09 | +84.7% |
| 2022 | -$0.59 | +47.3% |
| 2021 | -$1.12 | +64.9% |
| 2020 | -$3.19 | -39.3% |
| 2019 | -$2.29 | +53.8% |
| 2018 | -$4.96 | -770.2% |
| 2017 | -$0.57 | -385.0% |
| 2016 | $0.20 | +400.0% |
| 2015 | $0.04 | +102.0% |
| 2014 | -$2.04 | -628.6% |
| 2013 | -$0.28 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.18 | +28.0% | -800.0% |
| June 30, 2025 | -$0.02 | +83.3% | +93.3% |
| March 31, 2025 | -$0.30 | -200.0% | -20.0% |
| September 30, 2024 | -$0.25 | -525.0% | -108.3% |
| June 30, 2024 | -$0.12 | -180.0% | -20.0% |
| March 31, 2024 | -$0.10 | +50.0% | -150.0% |
| September 30, 2023 | -$0.04 | +85.7% | -126.7% |
| June 30, 2023 | $0.15 | +171.4% | +175.0% |
- Surgery Partners, Inc. showed an increase of +54.1% in Diluted EPS compared to the prior fiscal year.
- Over the 2013–2025 period, Surgery Partners, Inc.’s diluted eps has declined by 117.9% (from $0.28 per share (loss) to $0.61 per share (loss)).
- The most recent figure is from Surgery Partners, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 2, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: